APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer

BACKGROUND: Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3B (APOBEC3B) is a gene editing enzyme with cytidine deaminase activity and high expression of its mRNA in breast tumors have been shown to be associated with progressive cases and poor prognosis. In this study, we aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujiki, Yoshitaka, Yamamoto, Yutaka, Sueta, Aiko, Yamamoto-Ibusuki, Mutsuko, Goto-Yamaguchi, Lisa, Tomiguchi, Mai, Takeshita, Takashi, Iwase, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078135/
https://www.ncbi.nlm.nih.gov/pubmed/30093965
http://dx.doi.org/10.18632/oncotarget.25495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078135/
https://www.ncbi.nlm.nih.gov/pubmed/30093965
http://dx.doi.org/10.18632/oncotarget.25495

Ejemplares similares